CHICAGO EQUITY PARTNERS LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 136 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$803,000
+147.8%
472,535
+153.5%
0.02%
+140.0%
Q2 2018$324,000
+57.3%
186,400
+321.6%
0.01%
+66.7%
Q1 2017$206,00044,2100.01%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders